SCHEMBL9733852

SCHEMBL9733852

COC(=O)CC(C)C(=O)c1ccc(SC(=O)N(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
KCNA5 P22460 6/20 0.35
RAB9A P51151 2/20 0.35
HTT P42858 2/20 0.35
HPGD P15428 1/20 0.35
ACHE P22303 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
EGFR P00533 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9735344 0.81 PLK1 (0.45) ALDH1A1HTTHPGDMEN1KMT2A
SCHEMBL9780324 0.79 ALDH1A1 (0.40) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL9734549 0.76 CA1 (0.48) ALDH1A1KCNA5MEN1KMT2A
SCHEMBL10691601 0.76 ALDH1A1 (0.43) ALDH1A1HTTMEN1KMT2AMAPT
SCHEMBL9780181 0.75 KCNA5 (0.38) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL9733728 0.75 ALDH1A1 (0.51) ALDH1A1HDAC3HDAC4HDAC1HDAC7
SCHEMBL11312872 0.75 CA1 (0.50) ALDH1A1RAB9AHTTHPGDMEN1
SCHEMBL8535929 0.75 KCNA5 (0.49) ALDH1A1KCNA5HPGDMEN1KMT2A
SCHEMBL377862 0.74 CYP4F2 (0.51) ALDH1A1RAB9AHPGDKMT2AMAPT
SCHEMBL20244667 0.72 ALDH1A1 (0.53) ALDH1A1RAB9AHTTHPGDACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135940-A Antiallegens, antiinflammatory agents MERCK FROSST CANADA, INC. (CA) 1992-08-04 US disclosed
EP-0252639-A1 Leukotriene antagonists MERCK FROSST CANADA INC. (CA) 1988-01-13 EP disclosed
EP-0104885-B1 LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION, AND COMPOSITIONS CONTAINING THEM MERCK FROSST CANADA INC. (CA) 1986-06-04 EP disclosed
EP-0156233-A2 Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions MERCK & CO. INC. (US) 1985-10-02 EP disclosed
EP-0104885-A1 Leukotriene antagonists, their production, and compositions containing them MERCK FROSST CANADA INC. (CA) 1984-04-04 EP disclosed